Adam J Simon

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

Walter J Koroshetz, Max Kuhn, Madhav Thambisetty, 2012, Archives of neurology.

Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformation.

Alison R. Gregro, Georgia B McGaughey, M Katharine Holloway, 2007, Bioorganic & medicinal chemistry letters.

Macrocyclic inhibitors of beta-secretase: functional activity in an animal model.

M Katharine Holloway, Lixia Jin, Michelle Crouthamel, 2006, Journal of medicinal chemistry.

Effects of Exercise on EEG Activity and Standard Tools Used to Assess Concussion

Mayuresh V Kothare, David M Devilbiss, M. Kothare, 2019, Journal of healthcare engineering.

Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry.

Matthew C Wiener, Fanyu Meng, R. Hendrickson, 2010, Journal of proteome research.

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

Kevin Mills, Henrik Zetterberg, Niklas Mattsson, 2012, Biomarkers in medicine.

Biochemical and cell-based assays for characterization of BACE-1 inhibitors.

Xiao-Ping Shi, Amy S Espeseth, Min Xu, 2005, Analytical biochemistry.

Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.

Paul Zuck, Georgia B McGaughey, M Katharine Holloway, 2008, Journal of medicinal chemistry.

A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication.

James Inglese, Marc Ferrer, Berta Strulovici, 2004, Analytical biochemistry.